Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 5
1993 2
1994 3
1995 3
1996 2
1997 1
1998 2
1999 2
2000 6
2001 5
2002 3
2004 2
2005 5
2006 12
2007 15
2008 7
2009 3
2010 9
2011 13
2012 6
2013 9
2014 9
2015 18
2016 8
2017 11
2018 14
2019 24
2020 25
2021 26
2022 22
2023 10
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

259 results

Results by year

Filters applied: . Clear all
Page 1
Von Willebrand's Disease.
Leebeek FW, Eikenboom JC. Leebeek FW, et al. Among authors: eikenboom jc. N Engl J Med. 2016 Nov 24;375(21):2067-2080. doi: 10.1056/NEJMra1601561. N Engl J Med. 2016. PMID: 27959741 Review. No abstract available.
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
James PD, Connell NT, Ameer B, Di Paola J, Eikenboom J, Giraud N, Haberichter S, Jacobs-Pratt V, Konkle B, McLintock C, McRae S, R Montgomery R, O'Donnell JS, Scappe N, Sidonio R, Flood VH, Husainat N, Kalot MA, Mustafa RA. James PD, et al. Among authors: eikenboom j. Blood Adv. 2021 Jan 12;5(1):280-300. doi: 10.1182/bloodadvances.2020003265. Blood Adv. 2021. PMID: 33570651 Free PMC article.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
Heparin-Induced Thrombocytopenia.
Klarenbeek NB, Eikenboom JC. Klarenbeek NB, et al. Among authors: eikenboom jc. N Engl J Med. 2015 Nov 5;373(19):1882-3. doi: 10.1056/NEJMc1510993. N Engl J Med. 2015. PMID: 26535526 No abstract available.
Von Willebrand's Disease.
Leebeek FWG, Eikenboom JCJ. Leebeek FWG, et al. Among authors: eikenboom jcj. N Engl J Med. 2017 Feb 16;376(7):701-2. doi: 10.1056/NEJMc1616060. N Engl J Med. 2017. PMID: 28199817 No abstract available.
Lifecycle of Weibel-Palade bodies.
Mourik M, Eikenboom J. Mourik M, et al. Among authors: eikenboom j. Hamostaseologie. 2017 Jan 31;37(1):13-24. doi: 10.5482/HAMO-16-07-0021. Epub 2016 Dec 22. Hamostaseologie. 2017. PMID: 28004844 Review.
State of the art: von Willebrand disease.
James AH, Eikenboom J, Federici AB. James AH, et al. Among authors: eikenboom j. Haemophilia. 2016 Jul;22 Suppl 5:54-9. doi: 10.1111/hae.12984. Haemophilia. 2016. PMID: 27405677 Review.
[Dealing with COVID-19-associated coagulopathy].
Klok FA, den Exter PL, Huisman MV, Eikenboom J. Klok FA, et al. Among authors: eikenboom j. Ned Tijdschr Geneeskd. 2020 Apr 15;164:D5031. Ned Tijdschr Geneeskd. 2020. PMID: 32395964 Dutch.
Functional architecture of Weibel-Palade bodies.
Valentijn KM, Sadler JE, Valentijn JA, Voorberg J, Eikenboom J. Valentijn KM, et al. Among authors: eikenboom j. Blood. 2011 May 12;117(19):5033-43. doi: 10.1182/blood-2010-09-267492. Epub 2011 Jan 25. Blood. 2011. PMID: 21266719 Free PMC article. Review.
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19.
Roukens AHE, Pothast CR, König M, Huisman W, Dalebout T, Tak T, Azimi S, Kruize Y, Hagedoorn RS, Zlei M, Staal FJT, de Bie FJ, van Dongen JJM, Arbous SM, Zhang JLH, Verheij M, Prins C, van der Does AM, Hiemstra PS, de Vries JJC, Janse JJ, Roestenberg M, Myeni SK, Kikkert M, Yazdanbakhsh M, Heemskerk MHM, Smits HH, Jochems SP; in collaboration with BEAT-COVID group; in collaboration with COVID-19 LUMC group. Roukens AHE, et al. Nat Immunol. 2022 Jan;23(1):23-32. doi: 10.1038/s41590-021-01095-w. Epub 2021 Dec 22. Nat Immunol. 2022. PMID: 34937933
259 results